LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe, announced a signed distribution agreement with Mission Bio, the leader in single-cell DNA sequencing and multi-omics to accelerate discoveries and improve time-to-market for new therapeutics, to distribute Mission Bio’s Tapestri® solution in the Netherlands, Belgium and Luxembourg (Benelux) effective immediately. Mission Bio’s Tapestri Platform is the […]
Expanded In Vitro Modeling Tools Will Enable Researchers to Better Understand the Effects of Advanced Biologics and Gene Therapies BOSTON, Mass. – Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on […]
BRANFORD, Conn. — Isoplexis, the leader in single-cell functional proteomics, today announced a $135 million Series D financing comprised of $85 million in equity securities and a $50 million credit facility. The round was led by Perceptive Advisors with participation from other new investors, Ally Bridge Group and funds and accounts managed by BlackRock, as well as other existing investors. IsoPlexis will […]
NanoString’s GeoMx Digital Spatial Profiler Highlighted as a Versatile Platform for High Plex Spatial Analysis of RNA and Protein SEATTLE– NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the journal Nature Methods has selected spatially-resolved transcriptomics as their prestigious Method of the Year for 2020. […]
Proprietary in Situ Single-Cell Omics Technology Speeds Drug & Biomarker Discovery Vizgen, a life sciences company developing the next generation of in situ single-cell genomics, today announced the launch of its Pharma Accelerator Lab in response to high demand from leading pharmaceutical companies who are increasingly turning to single-cell and spatial transcriptomics solutions to accelerate […]
– ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf – ScaleReady’s mission is to make the business of cell and gene therapy practical and viable by providing the most simple, scalable and versatile manufacturing platform in the industry – ScaleReady will provide sales, marketing, and application support for customers globally ScaleReady, a joint venture […]
MENLO PARK, CA LevitasBio, a life science tools leader in label-free sample enrichment for cellular analysis, today announced the closing of its $18 million Series B financing round, led by Thalys Medical and joined by Series A lead investor Decheng Capital. The company is the manufacturer of the LeviCell – the world’s first label-free […]
WALTHAM, Mass. — Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex’s product offering will enable Thermo […]
Münster/Altenberge evorion biotechnologies GmbH is pleased to announce that it has closed a financing round with a group of new and existing investors and entered into a long-term strategic partnership with Jüke Systemtechnik GmbH. The goal of the financing round and strategic partnering is to: expand commercialization of evorion’s CellCity System as an integrated solution […]
Phasefocus, the Sheffield-based makers of Livecyte, the live cell high-content analysis system, are delighted to announce the opening of a second UK office based in BioCity, Nottingham. In response to a significant uptick in Livecyte sales in 2020 and a very positive outlook beyond, Phasefocus has decided to open a new dedicated Livecyte production facility. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
